Breau Leads Bioanalytical-Analytical Division at MPI Research: Mattawan-based MPI Research, the largest single-site preclinical contract research organization worldwide, announce that Alan P. Breau has joined the company as vice president of its bioanalytical and analytical services division. B/AS is one of the three core research divisions at MPI Research, along with drug safety evaluation and discovery services. Breau is a recognized expert in mass spectrometry, metabolite identification, pharmacokinetics, and bioanalytical chemistry. He is a cofounder of the Consortium for Metabonomic Toxicology and established a metabonomics group that provided toxicity assessments and biomarker support. He has more than 30 years of rich and varied scientific experience in the biopharmaceutical industry. Breau completed his undergraduate degree in chemistry at the Massachusetts Institute of Technology, did his post-doctoral fellowship with Harvard University and received his PhD in pharmacology from Vanderbilt University. MPI Research provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. More at www.mpiresearch.com.
(c) 2010, WWJ Newsradio 950. All rights reserved.